Primary medullary adenocarcinoma of the colon: Literature review and case series

IF 0.6 Q4 SURGERY
Hein Maung , Oliver Gregory , Thomas De Hoog , Matthew Hutchinson , Dr. Pith Beh Soh , Matthew Marino , Tobias Evans , Adrian Yeoh , Richard C. Turner
{"title":"Primary medullary adenocarcinoma of the colon: Literature review and case series","authors":"Hein Maung ,&nbsp;Oliver Gregory ,&nbsp;Thomas De Hoog ,&nbsp;Matthew Hutchinson ,&nbsp;Dr. Pith Beh Soh ,&nbsp;Matthew Marino ,&nbsp;Tobias Evans ,&nbsp;Adrian Yeoh ,&nbsp;Richard C. Turner","doi":"10.1016/j.sipas.2024.100254","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Medullary carcinoma of the colon is a rare subtype of adenocarcinoma, first described in 1999. Clinically known to have a favourable prognosis in comparison to poorly differentiated cancers, it is associated with deficient mismatch repair. This is an observational single center study of patients with medullary cancer, and comparison with the current literature.</div></div><div><h3>Methods</h3><div>We performed a search of the pathological database at our institution for medullary adenocarcinomas between the years of 2016–2023 and reviewed their clinical information to collect all relevant data including patient history, hospital admissions. surgery and clinic visits. We then performed a literature search using Pubmed for search terms medullary cancer/carcinoma of the colon/colorectum.</div></div><div><h3>Results</h3><div>11 patients were found in our database, 34 studies in the literature, 19 retrospective cohort studies (3144 patients) and 13 case reports. 81.8% (vs. 73.22% in cohort studies) were female patients. 8/11 patients' tumours had lympho-vascular invasion with 2/11 perineural involvement. Immunohistochemistry demonstrated 11/11 patients’ tumours with MLH1 and PMS2 loss, and presence of MSH2 and MSH6. Cohort studies demonstrated 302/1897 (15.92%) tumours had perineural invasion with 1133/2151 (52.67%) demonstrating lympho-vascular invasion. MLH1 testing was available for 192 patients, with 93.75% having loss of MLH1.</div></div><div><h3>Conclusion</h3><div>Our cohort of medullary cancer patients were similar to that in the literature, with regards to demographics, staging and tumour characteristics. A longer follow-up time is required for our cohort to analyze long term survival outcomes.</div></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"19 ","pages":"Article 100254"},"PeriodicalIF":0.6000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery in practice and science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666262024000214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

Medullary carcinoma of the colon is a rare subtype of adenocarcinoma, first described in 1999. Clinically known to have a favourable prognosis in comparison to poorly differentiated cancers, it is associated with deficient mismatch repair. This is an observational single center study of patients with medullary cancer, and comparison with the current literature.

Methods

We performed a search of the pathological database at our institution for medullary adenocarcinomas between the years of 2016–2023 and reviewed their clinical information to collect all relevant data including patient history, hospital admissions. surgery and clinic visits. We then performed a literature search using Pubmed for search terms medullary cancer/carcinoma of the colon/colorectum.

Results

11 patients were found in our database, 34 studies in the literature, 19 retrospective cohort studies (3144 patients) and 13 case reports. 81.8% (vs. 73.22% in cohort studies) were female patients. 8/11 patients' tumours had lympho-vascular invasion with 2/11 perineural involvement. Immunohistochemistry demonstrated 11/11 patients’ tumours with MLH1 and PMS2 loss, and presence of MSH2 and MSH6. Cohort studies demonstrated 302/1897 (15.92%) tumours had perineural invasion with 1133/2151 (52.67%) demonstrating lympho-vascular invasion. MLH1 testing was available for 192 patients, with 93.75% having loss of MLH1.

Conclusion

Our cohort of medullary cancer patients were similar to that in the literature, with regards to demographics, staging and tumour characteristics. A longer follow-up time is required for our cohort to analyze long term survival outcomes.
结肠原发性髓样腺癌:文献综述和病例系列
目的结肠髓样癌是腺癌的一种罕见亚型,于 1999 年首次被描述。临床上,与分化不良的癌症相比,髓样癌的预后较好,但它与错配修复缺陷有关。这是一项针对髓样癌患者的单中心观察性研究,并与现有文献进行了比较。方法我们在本机构的病理数据库中搜索了2016-2023年间的髓样腺癌患者,并回顾了他们的临床信息,收集了所有相关数据,包括患者病史、入院情况、手术情况和门诊情况。然后,我们使用 Pubmed 进行了文献检索,检索词为髓样癌/结肠癌/结直肠癌。结果在我们的数据库中发现了 11 名患者,文献中有 34 项研究,19 项回顾性队列研究(3144 名患者)和 13 项病例报告。81.8%(队列研究中为 73.22%)的患者为女性。8/11例患者的肿瘤有淋巴管侵犯,2/11例有神经周围受累。免疫组化结果显示,11/11 例患者的肿瘤有 MLH1 和 PMS2 缺失,但存在 MSH2 和 MSH6。队列研究显示,302/1897(15.92%)例肿瘤有神经周围侵犯,1133/2151(52.67%)例肿瘤有淋巴管侵犯。192名患者接受了MLH1检测,93.75%的患者存在MLH1缺失。我们的队列需要更长的随访时间来分析长期生存结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
0
审稿时长
38 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信